Celcuity (CELC) Cash & Equivalents Growth (3y) (2019 - 2025)
Celcuity (CELC) Cash & Equivalents Growth (3y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
24.73% |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-28.55% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
21.66% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Celcuity |
4.14 Bn |
3.42 Bn |
- |
161.92% |
| Date | Value |
|---|
| Dec 31, 2025 |
161.92% |
| Sep 30, 2025 |
8.91% |
| Jun 30, 2025 |
-11.52% |
| Mar 31, 2025 |
-40.52% |
| Dec 31, 2024 |
-35.61% |
| Sep 30, 2024 |
-48.14% |
| Jun 30, 2024 |
-9.90% |
| Mar 31, 2024 |
-3.69% |
| Dec 31, 2023 |
38.12% |
| Sep 30, 2023 |
23.44% |
| Jun 30, 2023 |
27.84% |
| Mar 31, 2023 |
25.91% |
| Dec 31, 2022 |
9.46% |
| Sep 30, 2022 |
52.31% |
| Jun 30, 2022 |
64.92% |
| Mar 31, 2022 |
74.54% |
| Dec 31, 2021 |
74.20% |
| Sep 30, 2021 |
187.35% |
| Jun 30, 2021 |
135.88% |
| Mar 31, 2021 |
138.58% |
